Lindbrook Capital, LLC - INOVIO PHARMACEUTICALS INC ownership

INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 191 filers reported holding INOVIO PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.85 and the average weighting 0.0%.

Quarter-by-quarter ownership
Lindbrook Capital, LLC ownership history of INOVIO PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$695
+49.1%
847
+183.3%
0.00%
Q4 2022$466299
+143.1%
0.00%
Q3 2022$01230.0%0.00%
Q2 2022$0
-100.0%
123
-85.0%
0.00%
Q1 2022$3,000
+200.0%
818
+427.7%
0.00%
Q3 2021$1,000
-66.7%
155
-51.1%
0.00%
-100.0%
Q2 2021$3,0003170.00%
Other shareholders

There were no reported owners of INOVIO PHARMACEUTICALS INC in Q4 2022.

NameSharesValueWeighting ↓
View complete list of INOVIO PHARMACEUTICALS INC shareholders